Found 6 matching trials
A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors PHASE1 This is a Phase 1, open-label, dose-escalation and cohort expansion study d...
Show More Location
Shanghai Gobroad Cancer Hospital China Pharmaceutical University
Learn More & Join Trial
A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors PHASE1 The goal of this clinical trial is to learn more about the side effects and...
Show More Location
Carolina BioOncology
Learn More & Join Trial
IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors PHASE1 This trial is a first-in-human, open-label, multi-center, dose escalation p...
Show More Location
The First Affiliated Hospital of Henan University of Science and Technology
Learn More & Join Trial
A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer PHASE2 This is a single-arm, multicenter, open-label Phase II clinical study evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular Carcinoma PHASE2 This is a Phase 2, open-label, multicenter,study designed to evaluate the s...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors PHASE1 This study is an open-label, multi-centre, single-arm, phase I clinical stu...
Show More Location
ZhongShan Hospital Fudan University
Learn More & Join Trial